Medical Psychology | Neuropsychology and Gender Studies & Center for Neuropsychological Diagnostics and Intervention (CeNDI), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Evidence-based Medicine, Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
J Parkinsons Dis. 2023;13(5):659-679. doi: 10.3233/JPD-225116.
Fatigue is one of the most common and debilitating non-motor symptoms among patients with Parkinson's disease (PD) and significantly impacts quality of life. Therefore, effective treatment options are needed.
To provide an update on randomized controlled trials (RCTs) including pharmacological and non-pharmacological (but non-surgical) treatments that examine the effects of fatigue on PD patients.
We searched the MEDLINE, EMBASE, PsycINFO, CENTRAL, and CINAHL databases for (cross-over) RCTs on pharmacological and non-pharmacological interventions for treating fatigue in PD patients until May 2021. Meta-analyses for random-effects models were calculated when two or more studies on the same treatment option were available using standardized mean differences (SMDs) with 95% confidence intervals (CIs).
Fourteen pharmacological and 16 non-pharmacological intervention RCTs were identified. For pharmacological approaches, a meta-analysis could only be performed for modafinil compared to placebo (n = 2) revealing a non-significant effect on fatigue (SMD = - 0.21, 95% CI - 0.74-0.31, p = 0.43). Regarding non-pharmacological approaches, physical exercise (n = 8) following different training approaches versus passive or placebo control groups showed a small significant effect (SMD = - 0.37, 95% CI - 0.69- - 0.05, p = 0.02) which could not be demonstrated for acupuncture vs. sham-acupuncture (SMD = 0.16, 95% CI - 0.19-0.50, p = 0.37).
Physical exercise may be a promising strategy to treat fatigue in PD patients. Further research is required to examine the efficacy of this treatment strategy and further interventions. Future studies should differentiate treatment effects on physical and mental fatigue as the different underlying mechanisms of these symptoms may lead to different treatment responses. More effort is required to develop, evaluate, and implement holistic fatigue management strategies for PD patients.
疲劳是帕金森病(PD)患者最常见和最具致残性的非运动症状之一,严重影响生活质量。因此,需要有效的治疗选择。
提供关于包括药物和非药物(但非手术)治疗的随机对照试验(RCT)的最新信息,这些试验检查了疲劳对 PD 患者的影响。
我们在 MEDLINE、EMBASE、PsycINFO、CENTRAL 和 CINAHL 数据库中搜索了截至 2021 年 5 月关于治疗 PD 患者疲劳的药物和非药物干预的(交叉)RCTs。当有两项或更多关于同一治疗选择的研究时,使用标准化均数差值(SMD)和 95%置信区间(CI)进行随机效应模型的荟萃分析。
确定了 14 项药物和 16 项非药物干预 RCT。对于药物方法,仅可以对莫达非尼与安慰剂(n=2)进行荟萃分析,结果显示对疲劳无显著影响(SMD=-0.21,95%CI-0.74-0.31,p=0.43)。关于非药物方法,与被动或安慰剂对照组相比,采用不同训练方法的体育锻炼(n=8)显示出较小的显著效果(SMD=-0.37,95%CI-0.69- -0.05,p=0.02),而针刺与假针刺(SMD=0.16,95%CI-0.19-0.50,p=0.37)之间则无法证明这一点。
体育锻炼可能是治疗 PD 患者疲劳的一种有前途的策略。需要进一步研究来检验这种治疗策略和其他干预措施的疗效。未来的研究应区分这些症状的身体和精神疲劳的治疗效果,因为这些症状的不同潜在机制可能导致不同的治疗反应。需要更多的努力来为 PD 患者开发、评估和实施整体疲劳管理策略。